EYES stock


Second Sight Medical Products Inc (EYES) to Initiate Study of Argus II in Better-Sighted Retinitis Pigmentosa Patients; Shares Rose 5%

Second Sight Medical Products Inc (NASDAQ:EYES) shares are up nearly 6% this morning, following the news that the company has received approval from …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts